Literature DB >> 11949823

Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.

M J T Verstegen1, D Troost S Leenstra, H Ijlst-Keizers, D A Bosch.   

Abstract

UNLABELLED: As the value of grading of ependymomas is currently debated we studied the expression of proliferation- and apoptosis-related proteins in these tumors as these mechanisms both are suggested to be important in tumor growth. We characterized the immunohistochemical expression of p53, Mdm2, Bcl-2, and Bax in 51 intracranial ependymomas. We also assessed the apoptosis- and proliferation-index, measured by MIB-1, PCNA-immunohistochemistry, and analyzed the clinical parameters. Of all used antibodies, the correlation with survival and the correlation among ordered categories was assessed. None of the analyzed immunohistochemical variables were significantly correlated with tumor grade. On the other hand, PCNA, MIB-1, and p53 were significantly related to the survival of the patient. In multivariate analysis, p53 was the only independent predictive variable (p = 0.0132).
CONCLUSION: The strongest predictors of survival in univariate analysis were the expression of PCNA, MIB-1 and p53. In multivariate analysis a p53 expression > 1% showed to be significantly related with a worse survival. The predicting value of p53 expression has to be confirmed by others before solid conclusions can be made. Apoptosis seems not to be an important mechanism in tumor growth in ependymomas. The expression of Mdm2, Bcl-2, and Bax were not related to survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949823     DOI: 10.1023/a:1014471714058

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  59 in total

1.  Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

Authors:  D Schiffer; P Cavalla; A Migheli; M T Giordana; L Chiadò-Piat
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.

Authors:  D A Reardon; R E Entrekin; J Sublett; S Ragsdale; H Li; J Boyett; J L Kepner; A T Look
Journal:  Genes Chromosomes Cancer       Date:  1999-03       Impact factor: 5.006

4.  Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.

Authors:  C Capoulade; B Bressac-de Paillerets; I Lefrère; M Ronsin; J Feunteun; T Tursz; J Wiels
Journal:  Oncogene       Date:  1998-03-26       Impact factor: 9.867

5.  Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy.

Authors:  L J Vanuytsel; E M Bessell; S E Ashley; H J Bloom; M Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

6.  Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.

Authors:  Y Wang; L Szekely; I Okan; G Klein; K G Wiman
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

Review 7.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

8.  Apoptosis and cell proliferation in human neuroepithelial tumors.

Authors:  D Schiffer; P Cavalla; A Migheli; A Chiò; M T Giordana; S Marino; A Attanasio
Journal:  Neurosci Lett       Date:  1995-08-04       Impact factor: 3.046

9.  Cytogenetic analysis of 109 pediatric central nervous system tumors.

Authors:  E Neumann; D K Kalousek; M G Norman; P Steinbok; D D Cochrane; K Goddard
Journal:  Cancer Genet Cytogenet       Date:  1993-11

10.  Ependymoma: internal correlations among pathological signs: the anaplastic variant.

Authors:  D Schiffer; A Chiò; H Cravioto; M T Giordana; A Migheli; R Soffietti; M C Vigliani
Journal:  Neurosurgery       Date:  1991-08       Impact factor: 4.654

View more
  16 in total

1.  Pediatric anaplastic parenchymal ependymoma: case report.

Authors:  Murat Kutlay; Ahmet Cetinkal; Serdar Kaya; Mehmet N Demircan; Murat Velioglu; Ufuk Berber
Journal:  Childs Nerv Syst       Date:  2010-11-26       Impact factor: 1.475

Review 2.  Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.

Authors:  Klara Kuncova; Ales Janda; Pavel Kasal; Josef Zamecnik
Journal:  Pathol Oncol Res       Date:  2009-03-20       Impact factor: 3.201

3.  Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

Authors:  Rebecca Senetta; Clelia Miracco; Salvatore Lanzafame; Luigi Chiusa; Rosario Caltabiano; Antonio Galia; Giulia Stella; Paola Cassoni
Journal:  Neuro Oncol       Date:  2010-11-08       Impact factor: 12.300

4.  Apoptosis and proliferation: correlation with p53 in astrocytic tumours.

Authors:  Chitra Sarkar; Asis Kumar Karak; Neera Nath; Mehar Chand Sharma; Ashok Kumar Mahapatra; Parthoprasad Chattopadhyay; Subrata Sinha
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

Review 5.  Ependymoma in children: molecular considerations and therapeutic insights.

Authors:  J-H Kim; Y Huang; A S Griffin; P Rajappa; J P Greenfield
Journal:  Clin Transl Oncol       Date:  2013-04-25       Impact factor: 3.405

Review 6.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

7.  Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.

Authors:  Lee Ridley; Ruman Rahman; Marie-Anne Brundler; David Ellison; James Lowe; Keith Robson; Emma Prebble; Inga Luckett; Richard J Gilbertson; Sheila Parkes; Vikki Rand; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2008-08-13       Impact factor: 12.300

8.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

9.  Fourth ventricular ependymoma with a distant intraventricular metastasis: Report of a rare case.

Authors:  Sudheer Ambekar; Manish Ranjan; Chandrajit Prasad; Vani Santosh; Sampath Somanna
Journal:  J Neurosci Rural Pract       Date:  2013-08

10.  Supratentorial ependymomas in children: Analysis of nine cases.

Authors:  George A Alexiou; Maria Moschovi; Kalliopi Stefanaki; Dimitrios Panagopoulos; Maria Tsotra; George Siozos; George Sfakianos; Neofytos Prodromou
Journal:  J Pediatr Neurosci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.